# China Resolute Integrity 34/38 mm Study

> **NCT03118531** · NA · COMPLETED · sponsor: **Medtronic Vascular** · enrollment: 40 (actual)

## Conditions studied

- Ischemic Heart Disease
- Stenotic Coronary Lesion
- Cardiovascular Diseases
- Arteriosclerosis
- Coronary Artery Disease

## Interventions

- **DEVICE:** Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System(34/38 mm)

## Key facts

- **NCT ID:** NCT03118531
- **Lead sponsor:** Medtronic Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2018-07-31
- **Final completion:** 2023-04-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118531, "China Resolute Integrity 34/38 mm Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03118531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*